No Small Cell Lung Cancer
Conditions
Interventions
treatment group:TCM treatment
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Non small cell lung cancers which were dignosised by pathology or cytology; (2) Under or prepared to Chemotherapy; (3) Postoperative: ECOG >=0-1, KPS>=80; Advanced:ECOG>=0-3, KPS>=50; (4) prediction survival time: Postoperative:>=6 months,Advanced:>=3 months; (5) Aged 18-75 years; (6) Neutrophil>1.5×10^9/L Platelet>100×10^9/LHGB>9.0g/dlTBil normaol or < 1.5 × ULN; AST (SGOT), ALT (SGPT) < 2.5 × ULN; Cr < 1.5 × ULN; (7) Sign the informed consent form, and has good compliance.
Exclusion criteria
Exclusion criteria: (1) Non small cell lung cancers which were not dignosised by pathology or cytology; (2) The pregnant women and lactation period women, psychotic patients; (3) The patient with serious uncontroled organic disease,such as function decompensated of herat, lung, liver, kidney; (4) Under other trials; (5) Allergic to the research medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregression Free Survival time;the finish rate of Chemotherapy;the syptom; | — |
Secondary
| Measure | Time frame |
|---|---|
| immune function;quality of life;Tumor Marke; | — |
Countries
China
Contacts
Public ContactLin Hongsheng
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed